These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38937771)

  • 21. What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries.
    Bøje RB; Bardou M; Mensah K; Rico Berrocal R; Giorgi Rossi P; Bonvicini L; Auzzi N; Taut D; Jiboc N; Tisler A; Reintamm K; Uusküla A; Teixeira M; Firmino-Machado J; Amorim M; Baia I; Lunet N; Michaylova R; Panayotova Y; Kotzeva T; Andersen B; Kirkegaard P;
    BMJ Open; 2024 May; 14(5):e079921. PubMed ID: 38760040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
    Fokom Domgue J; Futuh B; Ngalla C; Kakute P; Manjuh F; Manga S; Nulah K; Welty E; Schmeler K; Welty T
    Int J Cancer; 2020 Jul; 147(1):128-138. PubMed ID: 31633801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon.
    Pham MA; Benkortbi K; Kenfack B; Tincho Foguem E; Sormani J; Wisniak A; Lemoupa Makajio S; Manga E; Vassilakos P; Petignat P
    BMC Public Health; 2022 Mar; 22(1):548. PubMed ID: 35305588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter- and intra-observer agreement in the assessment of the cervical transformation zone (TZ) by visual inspection with acetic acid (VIA) and its implications for a screen and treat approach: a reliability study.
    Benkortbi K; Catarino R; Wisniak A; Kenfack B; Tincho Foguem E; Venegas G; Mulindi M; Horo A; Jeronimo J; Vassilakos P; Petignat P
    BMC Womens Health; 2023 Jan; 23(1):27. PubMed ID: 36658551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
    Lee F; Bula A; Chapola J; Mapanje C; Phiri B; Kamtuwange N; Tsidya M; Tang J; Chinula L
    BMC Cancer; 2021 Apr; 21(1):428. PubMed ID: 33882885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
    Racey CS; Gesink DC
    J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers and recommendations for a cervical cancer screening program among women in low-resource settings in Lagos Nigeria: a qualitative study.
    Olubodun T; Balogun MR; Odeyemi AK; Odukoya OO; Ogunyemi AO; Kanma-Okafor OJ; Okafor IP; Olubodun AB; Ogundele OOP; Ogunnowo B; Osibogun A
    BMC Public Health; 2022 Oct; 22(1):1906. PubMed ID: 36224656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women's preferences for communication with the cervical screening programme: A qualitative study.
    Ravindran R; Cotton S; Cruickshank M
    Cytopathology; 2020 Jan; 31(1):47-52. PubMed ID: 31677212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence.
    Xue P; Ng MTA; Qiao Y
    BMC Med; 2020 Jun; 18(1):169. PubMed ID: 32493320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population.
    Yang W; Jin X; Huang L; Jiang S; Xu J; Fu Y; Song Y; Wang X; Wang X; Yang Z; Meng Y
    BMC Cancer; 2024 Jun; 24(1):776. PubMed ID: 38937664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing cervical cancer re-screening in a semi-rural health district of Cameroon: a cohort study.
    Evina Bolo S; Kenfack B; Wisniak A; Tankeu G; Yakam V; Moukam A; Sormani J; Stoll B; Vassilakos P; Petignat P
    BMC Womens Health; 2024 Jan; 24(1):76. PubMed ID: 38281960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disparities in cervical cancer screening programs in Cameroon: a scoping review of facilitators and barriers to implementation and uptake of screening.
    Woks NIE; Anwi MM; Kefiye TB; Sama DJ; Phuti A
    Int J Equity Health; 2023 Aug; 22(1):156. PubMed ID: 37592286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in Limbé, Cameroon.
    Pierz AJ; Ajeh R; Fuhngwa N; Nasah J; Dzudie A; Nkeng R; Anastos KM; Castle PE; Adedimeji A
    Front Reprod Health; 2020; 2():561202. PubMed ID: 36304705
    [No Abstract]   [Full Text] [Related]  

  • 37. A qualitative exploration of women's perspectives and acceptability of including new cancer awareness information in all-clear breast or cervical screening results.
    Bamidele OO; Green T; Tookey S; Walabyeki J; Macleod U
    Eur J Cancer Care (Engl); 2022 May; 31(3):e13574. PubMed ID: 35293051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A stakeholder analysis to prepare for real-world evaluation of integrating artificial intelligent algorithms into breast screening (PREP-AIR study): a qualitative study using the WHO guide.
    Newlands R; Bruhn H; Díaz MR; Lip G; Anderson LA; Ramsay C
    BMC Health Serv Res; 2024 May; 24(1):569. PubMed ID: 38698386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motivations and barriers to cervical cancer screening among HIV infected women in HIV care: a qualitative study.
    Bukirwa A; Mutyoba JN; Mukasa BN; Karamagi Y; Odiit M; Kawuma E; Wanyenze RK
    BMC Womens Health; 2015 Oct; 15():82. PubMed ID: 26458898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes toward self-sampling for cervical cancer screening among primary care attendees living on the US-Mexico border.
    Penaranda E; Molokwu J; Hernandez I; Salaiz R; Nguyen N; Byrd T; Shokar N
    South Med J; 2014 Jul; 107(7):426-32. PubMed ID: 25010584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.